Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical data from its AI driven drug discovery programs. The company highlighted progress in oncology and rare disease candidates in ...
Amid fierce debate about prescription-drug prices and countless proposals to rein them in, there has been a point of widespread agreement: Those prices at least partly reflect the vast amount of time, ...
Yuandong Tian, who spent more than a decade as a research scientist director inside Meta's Fundamental AI Research lab, has surfaced as a co-founder of Recursive Superintelligence, a startup that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results